創勝集團-B(06628.HK)授出200萬份購股權
格隆匯6月25日丨創勝集團-B(06628.HK)發佈公告,於2025年6月25日,公司根據股份激勵計劃向3名獎勵承授人授出90,000股獎勵股份及向1名購股權承授人授出2,000,000份購股權,授出購股權的行使價每股股份1.48港元。
授出獎勵股份及購股權的理由爲,通過授出獎勵股份及購股權,給予獎勵承授人及購股權承授人激勵,以竭力爲公司及其聯屬公司的成功服務並獎勵有關人員的不懈努力以及向獎勵承授人及購股權承授人提供從股份增值中受益的機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.